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Abstract
Enhanced Recovery After Surgery (ERAS) is an evidence-based paradigm shift in perioperative care, proven to lower both 
recovery time and postoperative complication rates. The role of ERAS in several surgical disciplines was reviewed. In colo-
rectal surgery, ERAS protocol is currently well established as the best care. In gastric surgery, 2014 saw an establishment of 
ERAS protocol for gastrectomies with resulting meta-analysis showing ERAS effectiveness. ERAS has also been shown to 
be beneficial in liver surgery with many centers starting implementation. The advantages of ERAS in pancreatic surgery have 
been strongly established, but there is still a need for large-scale, multicenter randomized trials. Barriers to implementation 
were analyzed, with recent studies concluding that successful implementation requires a multidisciplinary team, a willingness 
to change and a clear understanding of the protocol. Additionally, the difficulty in accomplishing necessary compliance to 
all protocol items calls for new implementation strategies. ERAS success in different patient populations was analyzed, and 
it was found that in the elderly population, ERAS shortened the length of hospitalization and did not lead to a higher risk of 
postoperative complications or readmissions. ERAS utilization in the emergency setting is possible and effective; however, 
certain changes to the protocol may need to be adapted. Therefore, further research is needed. There remains insufficient 
evidence on whether ERAS actually improves patients’ course in the long term. However, since most centers started to 
implement ERAS protocol less than 5 years ago, more data are expected.
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Introduction
Enhanced Recovery After Surgery (ERAS) is an evidence-
based multimodal perioperative protocol focused on stress 
reduction and the promotion of a return to function [1]. 
ERAS has been proven to lower both recovery time and 
postoperative complication rates while being cost-effective 
at the same time [2, 3]. It fundamentally shifts the traditional 
patient care in surgical wards to one that standardizes it 
based on published evidence [4]. Inspired by Danish Pro-
fessor of surgery Henrik Kehlet, ERAS protocol questioned 
traditional perioperative care including: prolonged fasting, 
mobility limitations, mechanical bowel preparation, routine 
use of drains, and the slow return to eating normally post-
operatively [4]. Kehlet theorized that the avoidance of such 
perioperative doctrine shortens the length of hospitalization 
by reducing the metabolic stress, fluid overload, and insu-
lin resistance placed on the body [5]. Professors Kenneth 
Fearon and Olle Ljungqvist added postulates to the ERAS 
protocol, developing the ERAS study group in 2001 and the 
ERAS Society in 2010. The international ERAS study group 
consisted of surgeons and anesthesiologists who reviewed 
literature and evidence of the most optimal perioperative 
care [4]. They created an ERAS protocol of 20 items along 
with a database to support the implementation of these prin-
ciples. The protocol divided the perioperative period, into 
pre-, intra-, and postoperative time periods based on the 
 * Michał Pędziwiatr 
 michal.pedziwiatr@uj.edu.pl
1 2nd Department of General Surgery, Jagiellonian University 
Medical College, Kopernika 21, 31-501 Krakow, Poland
2 Centre for Research, Training and Innovation in Surgery 
(CERTAIN Surgery), Krakow, Poland
3 Carol Davila University of Medicine and Pharmacy, Sector 1, 
Strada Dionisie Lupu 37, 030167 Bucharest, Romania
4 Department of Medical Education, Jagiellonian University 
Medical College, św. Łazarza 16, 31-530 Krakow, Poland
 Medical Oncology (2018) 35:95
1 3
95 Page 2 of 8
aggregation of marginal gains theory. This theory identi-
fies, divides, and adapts each step taken through the entire 
perioperative patient journey to facilitate the efficient and 
safe progress from preoperative assessment to discharge 
and rehabilitation [6]. 2010 saw the establishment of the 
ERAS Society with the goal of an international network of 
regional and national expert centers that facilitated ERAS 
protocol utilization [5]. Currently, there is growing evidence 
that ERAS is beneficial in many other disciplines including 
colorectal, gastric, pancreatic, esophageal bariatric as well 
as in non-gastrointestinal specialties [7–10].
This care focuses on counseling preoperatively, optimiz-
ing nutrition, standardizing analgesia without opioid use, 
minimizing electrolyte and fluid imbalance, using the most 
minimally invasive approaches, and promoting early ambu-
lation and feeding [5]. See Fig. 1 for overview of ERAS 
items.
How does ERAS work?
The body physiologically responds to stress in a catabolic 
manner. The central nervous system mediates this, resulting 
in the production of various stress hormones and inflam-
matory mediators [5]. More importantly, insulin resistance 
develops. Unlike traditional care, ERAS aims to attenu-
ate the development of insulin resistance, a key element 
in prolonged recovery and increased morbidity. The larger 
the operation, the greater the graded response of resistance. 
Despite the developing hyperglycemia, a reduction of mus-
cle and fat glucose uptake occurs. The loss of lean body 
mass coupled with the reduced glucose uptake and storage 
in muscle leads to reduced muscle function. This impairs 
mobilization. Further, noninsulin-sensitive cells increase 
their glucose uptake. This increase can lead to several post-
operative complications, such as infections and cardiovas-
cular problems [11].
Beginning with preoperative counseling, clear informa-
tion to patients before surgery decreases anxiety, facilitates 
postoperative recovery and pain control, and increases care 
plan adherence, allowing for earlier recovery and discharge 
[12]. ERAS protocol suggests against the previously stand-
ard mechanical bowel preparation (MBP), which has been 
proven to result in dehydration, along with fluid and elec-
trolyte imbalances. MBP was meant to rid the large bowel 
of solid feces and lower the bacterial content; however, this 
practice in fact liquefies the feces which increases the risk 
of surgical spilling and does not reduce the number of bac-
terial organisms in the bowel [2]. Preoperative fasting has 
been a part of traditional surgery protocol to avoid pulmo-
nary aspiration; however, no evidence supports this. Pre-
operative fasting instead exacerbates the already increased 
metabolic stress found postoperatively [13]. A metabolically 
fed state for surgery can be achieved by the ingestion of a 
Fig. 1  Key components of 
ERAS protocol Active Patient Involvement
Whole Team Involvement
Pre-operative Intra-operative Post-operative
Pre-admission education
Early discharge planning
Reduced fasting duration
Carbohydrate loading
No/selective bowel prep
Venous thromboembolism
prophylaxis
Antibiotic prophylaxis
Pre-warming
Active warming
Opioid-sparing technique
Surgical techniques
Avoidance of prophylactic
NG tubes & drains
Early oral nutrition
Early ambulation
Early catheter removal
Use of chewing gum
Defined discharge criteria
Goal directed peri-operative fluid management
Pain & nausea management
Audit of compliance & outcomes
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clear carbohydrate-rich beverage before midnight and 2–3 h 
before surgery. This reduces preoperative thirst, hunger, 
anxiety, and postoperative insulin resistance [8]. The ana-
bolic state that carbohydrate loading produces in the patient 
causes less postoperative nitrogen and protein losses and 
better maintenance of mass and muscle strength [2].
Meta-analyses have shown that low molecular weight 
heparin (LMWH) is equally as effective as low-dose subcu-
taneous unfractionated heparin in reducing the occurrence 
of deep vein thrombosis, pulmonary embolism, and overall 
mortality in patients. LMWH is preferable because of its 
once a day dosing and lower risk of heparin-induced throm-
bocytopenia [12]. Research shows the preemptive control 
of possible anaerobic and aerobic infections using prophy-
lactic antibiotics is effective [14]. Studies support the fact 
that preservation of normal body temperature reduces wound 
infections, cardiac complications, bleeding, and transfusion 
requirements. This can be accomplished by forced air heat-
ing of the upper body, intravenous fluids given with extend-
ing heating to 2 h before and after surgery for additional 
benefits [13]. Traditional surgery protocol often included 
the dosing of IV fluids that outweighed the losses during 
surgery. By delaying the return of normal gastrointestinal 
functioning, impairing wound and anastomosis healing, 
and affecting tissue oxygenation, such regimes increased 
hospital stay. Evidence suggests that limiting postoperative 
IV sodium-rich fluid administration by stopping IV infu-
sions and beginning early oral fluids, even on the first day 
postoperatively, can reduce hospital stay and postoperative 
complications such as ileus [12].
According to patient experiences, postoperative nausea 
and vomiting is more stressful than pain. The risk factors 
for these symptoms include female gender, non-smokers, 
history of motion sickness, and postoperative use of opioids. 
Individuals with at least 2 of these should be administered 
either dexamethasone sodium phosphate prophylaxis at the 
beginning or serotonin receptor antagonists at the end of 
the surgical procedure [13]. Drainage should not be used 
after uncomplicated procedures, as it does not lower the 
risk or severity of anastomotic leaks [14]. The use of mini-
mally invasive surgical techniques has been shown to reduce 
complications, speed recovery, and lower pain. Nasogastric 
decompression should be avoided due to the occurrence of 
fever, atelectasis, and pneumonia [15]. Complete avoidance 
or at least removal of nasogastric tubes before the rever-
sal of anesthesia is vital in reducing the risk of pneumonia 
while supporting the progression to intake of solids [13]. 
Long acting premedication, such as opioids, long acting 
sedatives, and hypnotics, can prolong recovery by delaying 
mobilization and the resumption of a normal diet. An earlier 
return to normal diet both supports mobilization, energy, 
and protein supply and reduces starvation-induced insulin 
resistance. The early removal of urinary catheters supports 
mobilization [14]. To reduce the risk of ileus, strategies 
include epidural analgesia in open surgery, avoidance of opi-
oids and fluid overload, and oral laxatives usage early after 
surgery. Discharge should occur as soon as the patient has 
a solid food diet, bowel movements, orally controlled pain, 
sufficient mobility for self-care, and no complications requir-
ing hospital care [12]. What is probably the most important 
in ERAS—its aim is not to discharge a patient from hospital 
as soon as possible. It rather aims to prepare him for early 
discharge by making him fully capable of going home.
ERAS in different surgical disciplines
The use of ERAS has been most extensively studied in colo-
rectal surgery. A multicenter randomized LAFA trial, the 
paramount Dutch study, compared four groups of patients 
undergoing open/laparoscopic surgery with/without ERAS 
[16]. It was shown that a combination of ERAS and lapa-
roscopy was associated with significant improvements in 
postoperative recovery. Next RCTs and several subsequent 
meta-analyses clearly showed that the introduction of ERAS 
to colorectal surgery decreased postoperative morbidity 
by 40–50% (mainly non-surgical) and shortened LOS by 
2–3 days [17–19]. Therefore, Greco et al. concluded that 
new RCTs were not required to compare ERAS with the 
standard of care in colorectal surgery. Rather, it is apparent 
from current evidence that new policies are needed to help 
implement ERAS protocol worldwide [17]. Moreover, it has 
been demonstrated that a combination of ERAS and lapa-
roscopy helps eliminate some well-established risk factors 
for prolonged LOS and complications [20, 21]. Importantly, 
ERAS can be successfully implemented in both colonic and 
rectal resections providing similar outcomes and level of 
adherence to the protocol, even in patients with advanced 
cancer [22, 23]. The position of ERAS protocol in colorectal 
surgery is nowadays well established as the best care and it 
is very unlikely that future trials will change this.
While proposed for gastric surgeries, ERAS protocol imple-
mentation is still being studied [24–26]. In 2014, Yu et. al’s 
meta-analysis of 400 patients showed that postoperative hospi-
tal stay, time to first flatus, and hospital costs were significantly 
reduced in patients who received ERAS perioperative care 
[27]. Additionally in 2014, an international committee within 
the ERAS society assembled an evidence-based 25-item long 
protocol for those patients undergoing gastrectomies [28]. 
A 2015 meta-analysis, including 7 RCTs and 524 patients, 
showed that ERAS treatment was associated with shorter post-
operative hospitalization, less hospitalization expenditure, less 
pain, and better quality of life [29]. Then in 2018, a subse-
quent meta-analysis similarly showed ERAS led to shortened 
time to first flatus, postoperative hospital stay, postoperative 
CRP levels, and hospitalization fees. Due to the limitations 
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of the study, however, further larger and multicenter studies 
are warranted to validate the findings [30]. In particular, the 
use of drains in gastric surgery, not in compliance with ERAS 
protocol, had been debated in the past. However, a Cochrane 
review of total or subtotal gastrectomies performed between 
1996 and 2014, showed no evidence in support of drainage 
regarding morbidity-mortality, nor in the diagnosis or manage-
ment of leakage [31]. Lastly, early postoperative oral feeding 
as compared with traditional, or late, feeding is associated with 
shorter hospital length of stay and is not associated with an 
increase in clinically relevant complications [32].
ERAS has also been shown to be beneficial in liver sur-
gery and its implementation has started in many centers [33]. 
Some reports show that current practices in hepatic surgery 
already cover several items of the modern perioperative 
care protocols, as suggested in a 2014 study by Wong-Lun-
Hing et al [34]. However, this needs further optimization, 
standardization, and broader research. A step towards this 
standardization was the publication of the ERAS Society 
Recommendations in 2016 [35]. Additionally, it is impor-
tant to note a growing number of recently published trials, 
including randomized prospective studies, that confirm there 
is a place for ERAS in this surgical discipline. Although 
mentioned trials do not have an overwhelming number of 
subjects (62 patients in Kapritsou et al. study [36]; 160 in 
Qi et al. RCT [37]), they provide strong evidence of clinical 
safety and efficacy, even in major resections.
The advantages of ERAS in pancreatic surgery have been 
strongly established through a number of research papers, 
including both meta-analyses and guidelines; for example, 
a study on ERAS care post pancreaticoduodenectomy was 
published in 2012 [38]. Literature reviews agree that ERAS 
may be introduced without compromising patients’ safety, 
although there is still a need for large-scale, multicenter ran-
domized trials [39, 40]. It seems one of the greatest concerns 
arises around minimally invasive pancreatic surgery because 
the evidence for its safety in cancer patients is still limited 
[41, 42]. As with hepatic surgery, recent high-quality trials 
have provided new evidence in regard to the implementa-
tion of ERAS in pancreatic surgery. For instance, results of 
Takagi et al. RCT published in January 2018 showed not 
only significantly lower rates of complications and readmis-
sions, but also improved patients’ quality of life when treated 
with ERAS [43]. On the other hand, one has to bear in mind 
that pancreatic surgery is particularly prone to specific com-
plications such as delayed gastric emptying or pancreatic 
fistula formation which can severely affect both LOS and 
postoperative compliance with early enteral feeding.
Difficulties in ERAS implementation
A large body of evidence demonstrates the success rates of 
ERAS protocol, showing decreased recovery times, short-
ened hospital stays, reduced hospitals costs, and increased 
patient satisfaction. However, ERAS’s challenge to tradi-
tional surgical doctrine has led to slow implementation [44]. 
Every member of the team must overcome the resistance 
to change and embrace ERAS protocol [45]. Resistance to 
change, however, is just one of the many barriers. Addition-
ally, compliance to all protocol items is crucial and often 
difficult to accomplish. One single center study proved that 
a 50–90% increase in the compliance rate decreased com-
plication rates by 20% and the length of stay by 4 days [4]. 
Similarly, another single center study demonstrated that a 
compliance rate of at least 80% is needed to decrease the 
length of hospital stay, and, that this compliance rate takes 
approximately 6 months and the treatment of 30 patients to 
successfully achieve [46]. In 2015, The ERAS Compliance 
Group showed in a large-scale study on over 1500 colorectal 
cancer patients that increasing ERAS compliance correlates 
with fewer complications [47]. This trend was later con-
firmed by two studies observing patients undergoing laparo-
scopic surgery for colorectal cancer. The first study showed 
that the decrease in both the rate of complications and length 
of hospital stay was correlated with level of compliance to 
ERAS protocol; there was no correlation to patient specific 
comorbidities or stage of cancer. The second study further 
supported the validity of this trend, when it demonstrated 
a significant decrease in complication rates with increas-
ing compliance (35.7% vs. 36.4% vs. 16.4%, p = 0.0024) as 
well as a decrease in the severity of complications that did 
occur [20, 48].
This correlation between compliance and clinical out-
comes raises the issue on how to maximize patients’ adher-
ence to the protocol. Some authors suggest auditing patient 
compliance weekly, potentially allowing for the implemen-
tation of any necessary changes to the protocol [5, 49]. It is 
also important to educate patients [50]. With no doubt, the 
early implementation period is the most inconsistent when it 
comes to ERAS compliance. According to Pędziwiatr et al. a 
multidisciplinary team needs at least 40 cases and 6 months 
to reach satisfactory level of adherence to the protocol [46].
Still, reports from institutes that use ERAS in periopera-
tive care are optimistic. Compliance rate is usually above 
60% and can be as high as over 90% [20, 51, 52]. Even in 
groups with lower compliance (< 70%), implementation of 
all ERAS items is beneficial and improves short-term out-
comes [48]. The question is whether a high level of compli-
ance can be sustained in long-term observation. Roulin et al. 
found that over the 8-month study period, reasons for non-
compliance are usually (in almost 80% of cases) medically 
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justified and that they are mostly observed in the postopera-
tive period [53].
In another study, all members of the ERAS multidisci-
plinary team from nurses to surgeons were interviewed to 
better understand the barriers and enablers of ERAS. When 
asked what the largest hindrance is to successfully imple-
menting ERAS, some responded institutional barriers, such 
as a lack of nursing staff and financial resources. Another 
group blamed the lack of communication and collaboration 
within the team [44].
Recent studies claim that the successful implementation 
of ERAS protocol requires a multidisciplinary team coupled 
with a willingness to change and a clear understanding of 
how to utilize the protocol [5]. In their study on the barriers 
of ERAS utilization, Kahokehr et. al recommended that the 
keys to successful implementation were developing a mul-
tidisciplinary team, distributing patient educational mate-
rials, and modifying the postoperative ward into a patient 
friendly rehabilitation center. A prospective study on 425 
patients treated under ERAS guidelines in the Netherlands, 
Norway, Sweden, United Kingdom, and Denmark showed 
that the lowest compliance rates occurred postoperatively. 
The author called for patients to complete their own daily 
logs and the reeducation of the members of the team to clar-
ify their individual roles as well as the multidisciplinary 
protocol [54]. An additional study of 107 patients treated 
with ERAS guidelines in the Netherlands called for continu-
ous education to ensure compliance [55]. Kisielewski et al. 
found that Polish surgeons followed several ERAS elements 
such as antibiotic and antithrombotic prophylaxis, postopera-
tive oxygen therapy, and lack of nasogastric tubes. On the 
other hand, several elements were not followed. Surgeons 
were not willing to change their practice but were support-
ive of changes in anesthesiologist-dependent elements of 
perioperative care that did not interfere with their own work, 
such as restrictive fluid therapy and the use of transversus 
abdominis plane blocks [56].
ERAS in specific patient populations
Regarding the elderly population, a systematic review of 
16 studies including 5965 patients supported the safety of 
ERAS in the elderly, with similar prevalence of morbidity 
and mortality compared to a younger population [57]. Baek 
et al. found no difference in postoperative results between 
patients below and above 70 years of age following enhanced 
recovery protocol [58]. However, ERAS protocol requires 
active participation and adherence to it within the elderly 
population had yet to be studied. A study of ERAS proto-
col adherence compared 513 patients: 311 patients in the 
younger group and 202 in the older group [59]. The overall 
adherence to ERAS protocol had a median of 78% (67–85%) 
in younger and 74% (64–85%) in older patients. Adherence 
was 100% (83–100%) versus 100% (83–100%) for preop-
erative protocol, 80% (80–85%) versus 80% (75–100%) for 
intra-operative protocol, and 72% (76–81%) versus 69% 
(52–81%) for postoperative protocol. No significant differ-
ences were noted for any of the three phases, despite the 
older population having significantly more comorbidities, 
worse disability scores and more emergency procedures. 
One difference in the studied groups was that urinary cathe-
ters and nasogastric tubes were retained longer in the elderly 
population. However, no differences in urinary retention or 
postoperative ileus were observed [59]. Kisialeuski et al. 
further supported ERAS implementation in the elderly; 
the authors demonstrated again that even with higher ASA 
grades, ERAS shortened the length of hospitalization and 
did not lead to a higher risk of postoperative complications 
or readmissions [60]. Although there are relatively many 
studies in literature comparing younger patients with the 
elderly, there are discrepancies in the age cutoffs used in 
these studies. For example, Wang et al. [61], Bagnall et al. 
[57], and Kisialeuski et al. defined the cutoff as over 65 years 
[60], Baek et al. [58] and Slieker et al. [59] defined the cutoff 
as over 70 years old, and even further Verheijen et al defined 
the cutoff at 80 years old [62].
Postoperative complications and prolonged hospital 
stays remains a problem in emergency surgeries. For obvi-
ous reasons, not all ERAS items are possible to implement 
in the emergency setting (e.g., preoperative carbohydrate 
loading in mechanical bowel obstruction or limited feasi-
bility of minimally invasive surgery, needs for drains etc). 
Lohsiriwat et al. investigated the feasibility of implementing 
ERAS protocol in the setting of emergent colorectal surgery. 
He compared the surgical outcomes of patients treated with 
ERAS protocol with those receiving conventional postopera-
tive care in a matched case-control study. A reduction in hos-
pital stay, time to first flatus, and time to resume normal diet 
was found in those receiving ERAS based care, without an 
increase in 30-day readmission or postoperative complica-
tions. He concluded that implementation of selected ERAS 
items in the setting of emergency colorectal surgeries was 
feasible and effective. Limitations in this study included its 
small sample size and selective inclusion of low risk patients 
[63]. Gonenc et al. demonstrated safe usage of ERAS guide-
lines in certain gastrointestinal emergent surgeries. When 
comparing 47 patients undergoing emergency surgery for 
perforated peptic ulcers, treatment with ERAS protocol 
effectively decreased the length of hospital stay [64]. Wisely 
et al. investigated the utilization of ERAS protocol in 370 
patients undergoing emergent major abdominal surgery. The 
ERAS patient group had significantly reduced presence of 
catheters, drains, patient-controlled analgesia, urinary tract 
infections, urinary retention, and chest infections. While 
the results supported ERAS implementation in emergency 
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abdominal surgeries, only some of the ERAS guidelines 
were implemented and further research is needed [65]. This 
call for further trials was supported by Paduraru et. al’s sys-
tematic review of the successful implementation and surgi-
cal outcome of ERAS protocol for emergency surgeries. The 
authors showed that the number of employed ERAS items 
ranged from 11 to 18 of the 20 recommended by the ERAS 
Society for elective procedures; patients treated within the 
guidelines had fewer postoperative complications, shorter 
hospital stays, with equal or lower mortality rates in certain 
studies. It seems that ERAS utilization in emergency setting 
is possible and effective; however, certain changes to the 
protocol may need to be adapted. Therefore, further research 
is needed to fully establish the role of ERAS in decreasing 
major morbidity and mortality [66].
ERAS impact on long‑term outcomes
There is still very little evidence on how ERAS implemen-
tation benefits patients long term [5]. Reports have been 
published which suggest that enhanced recovery protocols 
can increase long-term survival; however, these results are 
quite recent and need to be studied further [67]. One of these 
reports, performed by Curtis et al., compared laparoscopy 
and open approach surgeries with ERAS protocol imple-
mentation in all patients; these additional variables made 
the results more controversial and less clear [59]. However, 
a Gustafsson et al. study has more clear conclusions. Gus-
tafsson et al. analyzed 5-year survival in cohorts with dif-
ferent adherences [68]. Patients who had higher compliance 
(≥ 70%) to the protocol had reduced risk of 5-year cancer-
specific death, HR 0.58 (95% CI 0.39–0.88). Restricted 
perioperative fluid therapy, one of the elements of ERAS 
protocol, has also been shown to be related to improved 
5-year survival (cancer-specific death, HR 0.45, 95% CI 
0.25–0.81) [69].
These results still do not provide enough sufficient 
evidence to be decisive on whether ERAS does actually 
improve patients course in the long term. We should expect 
more results in upcoming years, since most centers started 
to comprehend and implement enhanced recovery protocol 
less than 5 years ago.
Conclusions
Interest in the implementation of modern perioperative care 
pathways based on ERAS principles results from grow-
ing evidence that it is safe, feasible, and associated with 
improved outcomes. ERAS reduces complications, shortens 
LOS, and thus leads to economic benefits in the majority of 
surgical disciplines. However, there are still challenges in 
sustaining a high level of compliance with ERAS items in 
the long term as well as the introduction of ERAS to emer-
gency surgery. It shows clearly that changing surgical dog-
mas is more difficult that one could assume. Therefore, new 
implementation strategies are needed in order to increase the 
popularity and utilization of this approach.
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